Universität zu Köln

Frontzek, Fabian ORCID: 0000-0003-1705-3638, Ziepert, Marita, Nickelsen, Maike, Altmann, Bettina, Glass, Bertram, Haenel, Mathias, Truemper, Lorenz, Held, Gerhard, Bentz, Martin, Borchmann, Peter, Dreyling, Martin, Viardot, Andreas, Kroschinsky, Frank P., Metzner, Bernd, Staiger, Annette M., Horn, Heike, Ott, German, Rosenwald, Andreas, Loeffler, Markus, Lenz, Georg and Schmitz, Norbert (2021). Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial. Lancet Haematol., 8 (4). S. E267 - 11. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

Hentrich, Marcus, Berger, Marcel, Wyen, Christoph, Siehl, Jan, Rockstroh, Juergen K., Mueller, Markus, Faetkenheuer, Gerd, Seidel, Elisabeth, Nickelsen, Maike, Wolf, Timo, Rieke, Ansgar, Schuermann, Dirk, Schmidmaier, Ralf, Planker, Manfred, Alt, Juergen, Mosthaf, Franz, Engert, Andreas, Arasteh, Keikawus and Hoffmann, Christian (2012). Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study. J. Clin. Oncol., 30 (33). S. 4117 - 4124. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Schmitz, Norbert, Nickelsen, Maike, Ziepert, Marita, Haenel, Mathias, Borchmann, Peter, Schmidt, Christian, Viardot, Andreas, Bentz, Martin, Peter, Norma, Ehninger, Gerhard, Doelken, Gottfried, Ruebe, Christian, Truemper, Lorenz, Rosenwald, Andreas, Pfreundschuh, Michael, Loeffler, Markus and Glass, Bertram (2012). Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). Lancet Oncol., 13 (12). S. 1250 - 1260. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1470-2045